Trial Profile
An observational study investigating efficacy of switching from endovenous to subcutaneous abatacept in patients with rheumatoid arthritis in a real clinical experience
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Aug 2016
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 24 Aug 2016 New trial record